Literature DB >> 26160878

Potential role of hypoxia in early stages of Hodgkin lymphoma pathogenesis.

Frederik Wein1, Teresa Otto2, Pascal Lambertz1, Joachim Fandrey2, Martin-Leo Hansmann3, Ralf Küppers4.   

Abstract

A unique feature of the germinal center B cell-derived Hodgkin and Reed/Sternberg cells of classical Hodgkin lymphoma is their lost B cell phenotype and the aberrant expression of factors of other hematopoietic cell types, including ID2 and NOTCH1. As cellular dedifferentiation and upregulation of ID2 and NOTCH1 are typical consequences of a hypoxic response, we wondered whether hypoxia may impose an HRS cell-like phenotype in B cells. Culturing normal B cells or cell lines of germinal center-type diffuse large B-cell lymphoma under hypoxic conditions caused partial downregulation of several B cell markers, ID2 upregulation, and increased NOTCH1 activity. The hypoxic cells acquired further features of Hodgkin and Reed/Sternberg cells, including increased JUN expression, and enhanced NFκB activity. The Hodgkin and Reed/Sternberg cell-expressed epigenetic regulators KDM4C and PCGF2, as well as the phosphatase DUSP1 were partially induced in hypoxic B cells. Inhibition of DUSP1 was toxic for classical Hodgkin lymphoma cell lines. Thus, hypoxia induces key Hodgkin and Reed/Sternberg cell characteristics in mature B cells. We speculate that hypoxic conditions in the germinal center may impose phenotypic changes in germinal center B cells, promoting their survival and initiating their differentiation towards a Hodgkin and Reed/Sternberg cell-like phenotype. These may then be stabilized by transforming events in the Hodgkin and Reed/Sternberg precursor cells. Copyright© Ferrata Storti Foundation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26160878      PMCID: PMC4591764          DOI: 10.3324/haematol.2015.127498

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  54 in total

Review 1.  Germinal centres: role in B-cell physiology and malignancy.

Authors:  Ulf Klein; Riccardo Dalla-Favera
Journal:  Nat Rev Immunol       Date:  2008-01       Impact factor: 53.106

2.  Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma.

Authors:  Stephan Mathas; Martin Janz; Franziska Hummel; Michael Hummel; Brigitte Wollert-Wulf; Simone Lusatis; Ioannis Anagnostopoulos; Andreas Lietz; Mikael Sigvardsson; Franziska Jundt; Korinna Jöhrens; Kurt Bommert; Harald Stein; Bernd Dörken
Journal:  Nat Immunol       Date:  2005-12-20       Impact factor: 25.606

3.  MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival.

Authors:  Bei Zheng; Paolo Fiumara; Yang V Li; Georgios Georgakis; Virginia Snell; Mamoun Younes; Jean Nicolas Vauthey; Antonino Carbone; Anas Younes
Journal:  Blood       Date:  2003-04-10       Impact factor: 22.113

4.  Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling.

Authors:  Ralf Küppers; Ulf Klein; Ines Schwering; Verena Distler; Andreas Bräuninger; Giorgio Cattoretti; Yuhai Tu; Gustavo A Stolovitzky; Andrea Califano; Martin-Leo Hansmann; Riccardo Dalla-Favera
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

5.  Induction of ID2 expression by hypoxia-inducible factor-1: a role in dedifferentiation of hypoxic neuroblastoma cells.

Authors:  Tobias Löfstedt; Annika Jögi; Mikael Sigvardsson; Katarina Gradin; Lorenz Poellinger; Sven Påhlman; Håkan Axelson
Journal:  J Biol Chem       Date:  2004-07-13       Impact factor: 5.157

6.  Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B.

Authors:  Stephan Mathas; Michael Hinz; Ioannis Anagnostopoulos; Daniel Krappmann; Andreas Lietz; Franziska Jundt; Kurt Bommert; Fatima Mechta-Grigoriou; Harald Stein; Bernd Dörken; Claus Scheidereit
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

7.  Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma.

Authors:  F Jundt; O Acikgöz; S-H Kwon; R Schwarzer; I Anagnostopoulos; B Wiesner; S Mathas; M Hummel; H Stein; H M Reichardt; B Dörken
Journal:  Leukemia       Date:  2008-05-01       Impact factor: 11.528

Review 8.  Notch signaling in neuroblastoma.

Authors:  Sven Påhlman; Marie-Thérése Stockhausen; Erik Fredlund; Håkan Axelson
Journal:  Semin Cancer Biol       Date:  2004-10       Impact factor: 15.707

9.  NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha.

Authors:  Jordi Rius; Monica Guma; Christian Schachtrup; Katerina Akassoglou; Annelies S Zinkernagel; Victor Nizet; Randall S Johnson; Gabriel G Haddad; Michael Karin
Journal:  Nature       Date:  2008-04-23       Impact factor: 49.962

10.  Unique polycomb gene expression pattern in Hodgkin's lymphoma and Hodgkin's lymphoma-derived cell lines.

Authors:  Danny F Dukers; Joost C van Galen; Cindy Giroth; Patty Jansen; Richard G A B Sewalt; Arie P Otte; Hanneke C Kluin-Nelemans; Chris J L M Meijer; Frank M Raaphorst
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

View more
  6 in total

1.  Stimulation of the hypoxia pathway modulates chemotherapy resistance in Hodgkin's lymphoma cells.

Authors:  Stefanie Kewitz; Lars Kurch; Ines Volkmer; Martin S Staege
Journal:  Tumour Biol       Date:  2015-12-30

2.  Ulk1/FUNDC1 Prevents Nerve Cells from Hypoxia-Induced Apoptosis by Promoting Cell Autophagy.

Authors:  Li Wang; Peng Wang; He Dong; Shiduan Wang; Haichen Chu; Wei Yan; Xue Zhang
Journal:  Neurochem Res       Date:  2018-06-19       Impact factor: 3.996

Review 3.  mRNA-to-protein translation in hypoxia.

Authors:  Nancy T Chee; Ines Lohse; Shaun P Brothers
Journal:  Mol Cancer       Date:  2019-03-30       Impact factor: 27.401

4.  Systems Drug Discovery for Diffuse Large B Cell Lymphoma Based on Pathogenic Molecular Mechanism via Big Data Mining and Deep Learning Method.

Authors:  Shan-Ju Yeh; Tsun-Yung Yeh; Bor-Sen Chen
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

5.  H2A.B is a cancer/testis factor involved in the activation of ribosome biogenesis in Hodgkin lymphoma.

Authors:  Xuanzhao Jiang; Jiayu Wen; Elizabeth Paver; Yu-Huan Wu; Gege Sun; Amanda Bullman; Jane E Dahlstrom; David J Tremethick; Tatiana A Soboleva
Journal:  EMBO Rep       Date:  2021-07-19       Impact factor: 9.071

Review 6.  Invariant Natural Killer T Cells in Immune Regulation of Blood Cancers: Harnessing Their Potential in Immunotherapies.

Authors:  Pui Yeng Lam; Michael D Nissen; Stephen R Mattarollo
Journal:  Front Immunol       Date:  2017-10-23       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.